Highlights

  • FY26 sales rose 6.8% to USD 2,140.2 million.
  • Adjusted EBIT increased 14.1% to USD 321.9 million.
  • Adjusted net profit after tax rose 15.8% to USD 212.3 million.
  • Operating cash flow increased to USD 270.1 million.
  • Management guided to FY27 adjusted Earnings Per Share of US 158–170 cents.

Ansell Limited (ASX:ANN) manufactures protective products for healthcare and industrial applications, including surgical, examination and mechanical-protection gloves. Its FY26 results showed growth in both reported sales and adjusted earnings, while the company addressed changes in tariffs, input costs and Supply conditions. The distinction between reported performance, management adjustments and future guidance is central to interpreting its disclosures.

FY26 Sales, Earnings and Cash Flow

Ansell Limited (ASX:ANN) reported FY26 sales of USD 2,140.2 million, an increase of 6.8%, with organic constant-currency growth of 5.0%. Adjusted EBIT rose 14.1% to USD 321.9 million, taking the adjusted EBIT Margin to 15.0% from 14.1%. Adjusted net profit after tax increased 15.8% to USD 212.3 million, and adjusted earnings per share rose 17.8% to 148.6 US cents.

Operating cash flow increased 156.3% to USD 270.1 million. The company reported a full-year Dividend of 68.1 US cents per share, including a final dividend of 41.5 cents. It also reported net Debt declining by USD 52.3 million and Liquidity of USD 752 million. Adjusted earnings figures exclude specified items and should not be presented as statutory results.

Healthcare and Industrial Segment Activity

Ansell Limited (ASX:ANN) reported Healthcare segment sales of USD 1,192.9 million and Industrial sales of USD 947.3 million. Healthcare organic constant-currency growth was 6.4%, supported by Demand across its protective product categories. Industrial organic constant-currency growth was 3.3%, reflecting the performance of mechanical protection and other industrial products.

The company also identified approximately USD 15 million of Healthcare examination and single-use sales associated with customer purchases ahead of price increases. This amount was excluded from one of management’s adjusted growth measures. The distinction matters because purchasing ahead of a price change can affect comparisons between reporting periods. It should not be assumed that the same buying pattern will recur.

Tariffs, Supply Conditions and Productivity

Ansell Limited (ASX:ANN) described US tariffs and disruption to supply conditions as operating pressures during FY26. Its responses included sourcing adjustments and price increases. The company reported receiving approximately USD 12 million in Tariff refunds in July 2026, while the timing and amount of any additional refunds remained uncertain.

Ansell also reported reaching its target of USD 50 million in recurring annual savings under its Accelerated Productivity Investment Program. Pricing and cost initiatives both featured in management’s explanation of margin performance. However, the supplied material did not isolate the contribution of every measure. Changes in customer demand, freight expenses and the effectiveness of planned systems work remain relevant to future operating outcomes.

FY27 Guidance and Key Insights

Ansell Limited (ASX:ANN) guided to adjusted FY27 earnings per share of 158–170 US cents, compared with 148.6 cents in FY26. The company’s stated assumptions included Capital Expenditure of USD 45 million to USD 55 million and approximately USD 15 million of one-off pre-tax costs, principally related to an enterprise resource planning implementation. These are management expectations, not completed results.

The FY26 figures show growth in sales, adjusted earnings and operating cash flow. Future reports will clarify whether the company sustains volumes and margins while responding to tariffs, supply conditions and implementation costs.